Computational drug repurposing identifies N-acetylglucosamine as a potential therapeutic compound for CLN3 Batten disease
Computational drug repurposing identifies N-acetylglucosamine as a potential therapeutic compound for CLN3 Batten disease
biorxiv.org
paper